Cargando…

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

BACKGROUND: This study examined potential predictors of remission among patients treated for major depressive disorder (MDD) in a naturalistic clinical setting, mostly in the Middle East, East Asia, and Mexico. METHODS: Data for this post hoc analysis were taken from a 6-month prospective, noninterv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novick, Diego, Hong, Jihyung, Montgomery, William, Dueñas, Héctor, Gado, Magdy, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309785/ https://www.ncbi.nlm.nih.gov/pubmed/25653529 http://dx.doi.org/10.2147/NDT.S75498

Ejemplares similares

Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East
por: Hong, Jihyung, et al.
Publicado: (2017)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
por: Hong, Jihyung, et al.
Publicado: (2015)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
por: Hong, Jihyung, et al.
Publicado: (2015)

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2013)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
por: Novick, Diego, et al.
Publicado: (2016)

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
por: Novick, Diego, et al.
Publicado: (2013)

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2014)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
por: Ascher-Svanum, Haya, et al.
Publicado: (2013)

Schizophrenia Outpatient Health Outcomes study: twelve-month findings
por: Novick, Diego, et al.
Publicado: (2012)

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang, Jia, et al.
Publicado: (2018)

Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
por: Reed, Catherine, et al.
Publicado: (2013)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Previous disorders and depression outcomes in individuals with 12-month major depressive disorder in the World Mental Health surveys
por: Roest, Annelieke M., et al.
Publicado: (2021)

Effect of Personality Traits on Sustained Remission Among Patients with Major Depression: A 12-Month Prospective Study
por: Nogami, Waka, et al.
Publicado: (2022)

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
por: Novick, Diego, et al.
Publicado: (2017)

Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders
por: Kim, Ha-Yeon, et al.
Publicado: (2021)

Twelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission
por: Charnsil, Chawanun, et al.
Publicado: (2012)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Cognitive remission: a novel objective for the treatment of major depression?
por: Bortolato, Beatrice, et al.
Publicado: (2016)

Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
por: Alten, Rieke, et al.
Publicado: (2017)

Incidence of diabetic peripheral neuropathic pain in primary care – a retrospective cohort study using the United Kingdom General Practice Research Database
por: Reed, Catherine, et al.
Publicado: (2013)

Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
por: Brugnoli, Roberto, et al.
Publicado: (2012)

Assessment of cerebrovascular reactivity during major depression and after remission of disease
por: Vakilian, Alireza, et al.
Publicado: (2010)

Excess cost of non-remission among outpatients with major depressive disorder
por: Woo, Jong-Min, et al.
Publicado: (2014)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder
por: Korgaonkar, Mayuresh S., et al.
Publicado: (2019)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021)

Clinical predictors associated with full remission versus episode of major depressive disorder outpatients: the experience at a teaching hospital in Taiwan
por: Yeh, Mei-Yu, et al.
Publicado: (2014)

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
por: Nash, Abigail I, et al.
Publicado: (2019)

Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
por: Lee, Jiyeong, et al.
Publicado: (2015)

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
por: Papalexi, Eugenia, et al.
Publicado: (2022)

Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
por: Bosello, Silvia, et al.
Publicado: (2011)

Clinical validity of a population database definition of remission in patients with major depression
por: Sicras-Mainar, Antoni, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u95jo4b0uvdt1m9ri3crlhif0v